NCT06804811 - A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo | Biotech Hunter

Enrollment

250

Participants

Timeline

Start Date

October 15, 2025

Primary Completion Date

April 30, 2027

Study Completion Date

December 1, 2027

Conditions

NonSegmental Vitiligo

Interventions

DRUG

Ruxolitinib Cream

Ruxolitinib cream applied topically to the affected area as a thin film twice daily.

DRUG

Vehicle Cream

Matching vehicle cream applied topically to the affected area as a thin film twice daily.

Trial Locations (2)

RECRUITING

Herlev and Gentofte Hospital, Hellerup

RECRUITING

Care Clinic Sp. Z O.O., Katowice